<SEC-DOCUMENT>0001213900-25-030101.txt : 20250409
<SEC-HEADER>0001213900-25-030101.hdr.sgml : 20250409
<ACCEPTANCE-DATETIME>20250409083037
ACCESSION NUMBER:		0001213900-25-030101
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250406
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250409
DATE AS OF CHANGE:		20250409

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			180 Life Sciences Corp.
		CENTRAL INDEX KEY:			0001690080
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				813832378
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38105
		FILM NUMBER:		25823900

	BUSINESS ADDRESS:	
		STREET 1:		3000 EL CAMINO REAL
		STREET 2:		BLDG 4, STE 200
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94306
		BUSINESS PHONE:		650-507-0669

	MAIL ADDRESS:	
		STREET 1:		3000 EL CAMINO REAL
		STREET 2:		BLDG 4, STE 200
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94306

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KBL MERGER CORP. IV
		DATE OF NAME CHANGE:	20161115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0237417-8k_180life.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ATNF="http://180lifesciences.com/20250406">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_ATNF_180lifesciences.com_20250406 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20250406_20250406 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001690080 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000004" name="dei:EntityCentralIndexKey">0001690080</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="atnf-20250406.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-04-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001690080</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-06</xbrli:startDate>
        <xbrli:endDate>2025-04-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-062025-04-06_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001690080</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-06</xbrli:startDate>
        <xbrli:endDate>2025-04-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-062025-04-06_custom_WarrantsToPurchaseSharesOfCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001690080</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:WarrantsToPurchaseSharesOfCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-06</xbrli:startDate>
        <xbrli:endDate>2025-04-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM&#160;<span id="xdx_902_edei--DocumentType_c20250406__20250406_zTWQKYk1z7af"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO SECTION 13 OR 15(d) OF THE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported):&#160;<b><span id="xdx_900_edei--DocumentPeriodEndDate_c20250406__20250406_zsXMo4JcEEa2"><ix:nonNumeric contextRef="AsOf2025-04-06" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">April 6, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_909_edei--EntityRegistrantName_c20250406__20250406_z8W6rm1hoT4a"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000011" name="dei:EntityRegistrantName">180 LIFE SCIENCES CORP.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20250406__20250406_z7yKSJZvI759"><ix:nonNumeric contextRef="AsOf2025-04-06" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityFileNumber_c20250406__20250406_zCEbafZtfSxl"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000013" name="dei:EntityFileNumber">001-38105</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20250406__20250406_zk3Yprfnk0W7"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000014" name="dei:EntityTaxIdentificationNumber">90-1890354</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or Other Jurisdiction<br/>
    of Incorporation)</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    File Number)</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer<br/>
    Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20250406__20250406_zutq58tAH7Ki"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000015" name="dei:EntityAddressAddressLine1">3000 El Camino Real</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressAddressLine2_c20250406__20250406_zn4nLkPx00z9"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000016" name="dei:EntityAddressAddressLine2">Bldg. 4</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressAddressLine3_c20250406__20250406_zdIVThoTvmM3"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000017" name="dei:EntityAddressAddressLine3">Suite 200</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressCityOrTown_c20250406__20250406_z1H74Y0YQedk"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000018" name="dei:EntityAddressCityOrTown">Palo Alto</ix:nonNumeric></span>,&#160;<span id="xdx_900_edei--EntityAddressStateOrProvince_c20250406__20250406_zlPnu61Idqu3"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000019" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span></b></span></p></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityAddressPostalZipCode_c20250406__20250406_zfvsxJ8KWKWi"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000020" name="dei:EntityAddressPostalZipCode">94306</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of Principal Executive Offices)</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code:&#160;<b><span style="text-decoration: underline">(<span id="xdx_90A_edei--CityAreaCode_c20250406__20250406_zKOTluUZofS8"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000021" name="dei:CityAreaCode">650</ix:nonNumeric></span>)&#160;<span id="xdx_90C_edei--LocalPhoneNumber_c20250406__20250406_zI0NybqCxjua"><ix:nonNumeric contextRef="AsOf2025-04-06" id="Fact000022" name="dei:LocalPhoneNumber">507-0669</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (<i>see&#160;</i>General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15pt; text-align: justify; text-indent: -0.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--WrittenCommunications_c20250406__20250406_zVwmT8Xqu5bi"><ix:nonNumeric contextRef="AsOf2025-04-06" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications
    pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SolicitingMaterial_c20250406__20250406_z8lz5N4KAeuf"><ix:nonNumeric contextRef="AsOf2025-04-06" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20250406__20250406_zeMtezI9261a"><ix:nonNumeric contextRef="AsOf2025-04-06" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20250406__20250406_zP4yn7QPWF4f"><ix:nonNumeric contextRef="AsOf2025-04-06" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="white-space: nowrap; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="white-space: nowrap; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--Security12bTitle_c20250406__20250406__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zb7ZMUKAszqb"><ix:nonNumeric contextRef="From2025-04-062025-04-06_custom_CommonStockParValue0.0001PerShareMember" id="Fact000027" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--TradingSymbol_c20250406__20250406__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zaKHMKAfLGe8"><ix:nonNumeric contextRef="From2025-04-062025-04-06_custom_CommonStockParValue0.0001PerShareMember" id="Fact000028" name="dei:TradingSymbol">ATNF</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_906_edei--SecurityExchangeName_c20250406__20250406__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zNxPaghGD52l"><ix:nonNumeric contextRef="From2025-04-062025-04-06_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span> Stock
    Market LLC</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--Security12bTitle_c20250406__20250406__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockMember_z4NSnuySytq9"><ix:nonNumeric contextRef="From2025-04-062025-04-06_custom_WarrantsToPurchaseSharesOfCommonStockMember" id="Fact000030" name="dei:Security12bTitle">Warrants to purchase shares of Common Stock</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--TradingSymbol_c20250406__20250406__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockMember_z4icfhhYdGB1"><ix:nonNumeric contextRef="From2025-04-062025-04-06_custom_WarrantsToPurchaseSharesOfCommonStockMember" id="Fact000031" name="dei:TradingSymbol">ATNFW</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_902_edei--SecurityExchangeName_c20250406__20250406__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockMember_zl7BUs6vyEah"><ix:nonNumeric contextRef="From2025-04-062025-04-06_custom_WarrantsToPurchaseSharesOfCommonStockMember" format="ixt-sec:exchnameen" id="Fact000032" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span> Stock
    Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company&#160;<span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20250406__20250406_zwnZliBbHo99"><ix:nonNumeric contextRef="AsOf2025-04-06" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement</b><b>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On,
and effective on, April 6, 2025 (the &#8220;<span style="text-decoration: underline">Effective Date</span>&#8221;), 180 Life Sciences Corp. (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;,
&#8220;<span style="text-decoration: underline">we</span>&#8221; and &#8220;<span style="text-decoration: underline">us</span>&#8221;), entered into a Confidential Settlement Agreement and Release (the &#8220;<span style="text-decoration: underline">Settlement
Agreement</span>&#8221;) with AmTrust International Underwriters DAC (&#8220;<span style="text-decoration: underline">AmTrust</span>&#8221;), and its wholly-owned subsidiary, AmTrust
Financial Services, Inc. (&#8220;<span style="text-decoration: underline">AFSI</span>&#8221;). Pursuant to the Settlement Agreement, the Company and AmTrust agreed to resolve
certain ongoing litigation and disputes relating to the Company&#8217;s pre-merger directors&#8217; and officers&#8217; insurance policy,
as previously disclosed (the &#8220;<span style="text-decoration: underline">Coverage Action</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Settlement Agreement, the Company agreed to (i) pay AmTrust a cash payment of $250,000 (the &#8220;<span style="text-decoration: underline">Settlement
Sum</span>&#8221;) within 20 days of the Effective Date, and (ii) issue AFSI 509,707 shares of the Company&#8217;s
common stock, par value $0.0001 per share (the &#8220;<span style="text-decoration: underline">Settlement Shares</span>&#8221;), within three business days of the Effective Date.
The Settlement Shares were valued at $575,000 (the &#8220;<span style="text-decoration: underline">Shares Value</span>&#8221;), based on the volume-weighted average price of
the Company&#8217;s common stock over the 30 trading days preceding the Effective Date and are subject to customary anti-dilution protections,
including adjustments for stock splits, combinations, and stock dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
ten days after delivery of both the Settlement Sum and the Settlement Shares, the parties have agreed to file a joint stipulation of
dismissal with prejudice of the Coverage Action.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the settlement, the Company and AmTrust provided each other broad mutual releases of all claims, known and unknown, arising
out of or relating to, among other things, the Coverage Action, certain claims relating to a Securities and Exchange Commission (SEC)
investigation of certain of the Company&#8217;s per-merger officers, including Dr. Marlene Krauss, a lawsuit filed by the Company against
Dr. Krauss, certain cross claims made by the Company against AmTrust, and related insurance claims and matters, including any claims
for bad faith, breach of the implied covenant of good faith and fair dealing, or alleged unfair insurance practices. These releases extend
to affiliates, officers, directors, employees, agents, and other related parties of both entities. The Settlement Agreement expressly
provides that it does not release the parties from obligations arising under the Settlement Agreement itself.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the issuance of the Settlement Shares and pursuant to the Settlement Agreement, the Company agreed to provide AFSI with
certain registration rights. Specifically, the Company is obligated to use commercially reasonable efforts to file a registration statement
on Form S-1 (or Form S-3, if available) with the SEC within 45 days of the Effective Date to register the resale of the Settlement Shares
(the &#8220;<span style="text-decoration: underline">Resale Registration Statement</span>&#8221;). The Company has further agreed to use commercially reasonable efforts to cause
the Resale Registration Statement to be declared effective within 60 days following the Effective Date, or, in the event of SEC notice
that the Registration Statement will not be reviewed, by the third business day thereafter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to keep the Resale Registration Statement continuously effective until such time as AFSI no longer holds any Settlement
Shares, and to bear all related costs and expenses in connection with such registration, excluding AFSI&#8217;s legal fees. Additionally,
the Company must provide legal opinion coverage at its expense, if necessary, to enable AFSI to rely on Rule 144 resale exemptions after
six months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company fails to file or cause the Resale Registration Statement to become effective within 105 days after the Effective Date, if
the prospectus included in the registration statement can no longer be relied upon, or if the Company fails to maintain the effectiveness
of the Resale Registration Statement (each, a &#8220;<span style="text-decoration: underline">Registration Statement Failure Event</span>&#8221;), the Company is required to
pay liquidated damages equal to 3.0% of the Shares Value for each such failure and for each month such failure continues, subject to
a cap of 33.0% of the Shares Value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Settlement Agreement included customary representations and warranties of the parties, including representations from AFSI confirming
its status as an accredited investor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summary of the Settlement Agreement is a summary only and is qualified in its entirety by reference to the Settlement Agreement,
a copy of which is attached hereto as&#160;<span style="text-decoration: underline">Exhibit&#160;10.1</span>&#160; and is incorporated into this&#160;<span style="text-decoration: underline">Item 1.01</span>&#160;by
reference in its entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02 Unregistered Sales of Equity Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained above in&#160;<span style="text-decoration: underline">Item 1.01</span>&#160;related to the 509,707 Settlement Shares is hereby incorporated by reference
into this&#160;<span style="text-decoration: underline">Item 3.02</span>. The Settlement Shares were issued without registration under the Securities Act of 1933, as amended
(the &#8220;<span style="text-decoration: underline">Securities Act</span>&#8221;), since the offer and sale of such shares did not involve a public offering and the recipient
was an &#8220;<span style="text-decoration: underline">accredited investor</span>&#8221;. The securities were offered without any general solicitation by us or our representatives.
No underwriters or agents were involved in the foregoing offer and we paid no underwriting discounts or commissions. The securities are
subject to transfer restrictions, and the securities contain an appropriate legend stating that such securities have not been registered
under the Securities Act and may not be offered or sold absent registration or pursuant to an exemption therefrom.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="ea023741701ex10-1_180life.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential Settlement Agreement and Release dated April 6, 2025, between 180 Life Sciences Corp., AmTrust International Underwriters DAC and AmTrust Financial Services, Inc.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>180 LIFE SCIENCES CORP.</b></span></td></tr>
  <tr>
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 9, 2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Blair
    Jordan</i></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blair Jordan</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>













<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kU1uwjAQhU/AHUZRlyg4oT9qdm1EUdXQRoBotyZMikXiicYOhSP1lnUcUFm0liXLnvneeyMHwTCY0pOqkOHjcZ7BEuumkhZhjiUy6gJdR/r8koA75/ipjGWprb+ewZQcg465DcXavfvOvTK4SUBcj8TdKL4BMU7G95DPgkFXT0mXaoPaKlmB1BvImRpWaCUfe4WlPJCm+uidVshGkU4gCkVf/oZYRDG80l5+Ee8MZFkaDIZ+DYIpU9u4rsnBou5ImFRYOzvT07/bpylaY6lO3iV3s5kl5S0XW2lwsZWM5q10E9akF5aK3QzrNbKDIhHHkXg45TmzYAmaEw3G40Al9ALgFf5wvtDPJa9k1aIIhRBRjuwz/ON6KTuERjLsOxauehoa9zs+xNnzBweMldc= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea023741701ex10-1_180life.htm
<DESCRIPTION>CONFIDENTIAL SETTLEMENT AGREEMENT AND RELEASE DATED APRIL 6, 2025, BETWEEN 180 LIFE SCIENCES CORP., AMTRUST INTERNATIONAL UNDERWRITERS DAC AND AMTRUST FINANCIAL SERVICES, INC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 10.1</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>confidential
SETTLEMENT AGREEMENT AND RELEASE</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Settlement Agreement and Release (the &ldquo;Agreement&rdquo;) is made and entered into by and between 180 Life Sciences Corp., and its
past, present, or future members, managers, parents, subsidiaries, affiliates, divisions, associated entities, partners, directors, officers,
employees, owners, shareholders, principals, insurers, reinsurers, agents, brokers, counselors, representatives, attorneys, and all persons
acting by, through, under, or in concert with any of them, and including their respective predecessors, successors, trustees, executors,
administrators, heirs, and assigns (collectively, &ldquo;180 Life&rdquo;) on the one hand, and AmTrust International Underwriters DAC,
and its past, present, or future parents, subsidiaries, affiliates, divisions, associated entities, partners, directors, officers, employees,
owners, shareholders, principals, insurers, reinsurers, agents, brokers, counselors, representatives, attorneys, and all persons acting
by, through, under, or in concert with any of them, and including their respective predecessors, successors, trustees, executors, administrators,
heirs, and assigns (collectively, &ldquo;AmTrust&rdquo;), and AmTrust Financial Services, Inc., a Delaware Corporation, a wholly-owned
subsidiary of AmTrust (&ldquo;AFSI&rdquo;), solely for purposes of Sections 1(c) and 17(a), on the other hand. At times herein, AmTrust,
AFSI, and 180 Life will be referred to as a &ldquo;Party&rdquo; and/or collectively as the &ldquo;Parties.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RECITALS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
AmTrust issued Policy No. EUC1001782 00 to KBL Merger Corp. IV (&ldquo;KBL&rdquo;) for <B>Claims</B><SUP>1</SUP> first made during the
<B>Policy Period</B> of June 7, 2017 to June 7, 2018 (the &ldquo;Policy&rdquo;). The <B>Policy Period</B> was subsequently extended by
endorsement to expire on November 9, 2020. The Policy&rsquo;s Directors and Officers and Public Company Liability Coverage Element contains
an each <B>Claim</B> and Aggregate Limit of Liability of $3,000,000, subject to a $250,000 per <B>Securities Claim</B> Retention. The
Limit of Liability and any applicable Retention(s) are inclusive of <B>Defense Costs</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on November 6, 2020, KBL, a special purpose acquisition company then under management that included Dr. Marlene Krauss and George Hornig
as officers and directors, merged with 180 Life Corp. and its associated entities (the &ldquo;Merger&rdquo;). Dr. Krauss and Mr. Hornig
resigned from KBL as part of the Merger. The surviving entity following the Merger changed its name to 180 Life.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
after the Merger closed, the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) commenced an investigation into the Merger
(the &ldquo;SEC Investigation&rdquo;). The SEC served subpoenas (the &ldquo;SEC Subpoenas&rdquo;) on Dr. Krauss and Mr. Hornig as part
of the SEC Investigation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on or about August 19, 2021, Dr. Marlene Krauss filed a Complaint (the &ldquo;Advancement Complaint&rdquo;) and commenced a legal action
against 180 Life in the Chancery Court of Delaware (the &ldquo;Delaware Court&rdquo;) entitled <I>Marlene Krauss, M.D. v. 180 Life Sciences
Corp.</I>, Case No. 2021-0714-LWW (the &ldquo;Advancement Action&rdquo;), seeking in part indemnification from 180 Life in relation to
the SEC Investigation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify">Terms in bold are defined in the Policy.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on September 1, 2021, 180 Life filed a lawsuit against Dr. Krauss, KBL Merger Sub, and KBL Healthcare Management, Inc. in the Court of
Chancery of the State of Delaware, Case No. 2021-0754, alleging that Dr. Krauss and two of her alter ego companies breached fiduciary
duties, made false attestations of financial statements, and engaged in other unauthorized acts that caused 180 Life to suffer millions
of dollars in damages (the &ldquo;180 Life Lawsuit&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
in response to the 180 Life Lawsuit, Dr. Krauss asserted affirmative defenses and filed a Counterclaim and Third-Party Complaint against
180 Life.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on October 6, 2021, 180 Life advised AmTrust that it had been served with the Counterclaim and Third-Party Complaint in the 180 Life
Lawsuit, and tendered those matters to AmTrust for coverage under the Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on December 30, 2021, AmTrust denied coverage to 180 Life for the Counterclaim and Third-Party Complaint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on or about March 7, 2023, the Delaware Court in the Advancement Action granted Dr. Krauss&rsquo;s Motion for Summary Judgment in part,
and subsequently entered an Order requiring 180 Life to make certain advance payments to Dr. Krauss (the &ldquo;Advancement Order&rdquo;).
Subsequent thereto, 180 Life made a series of monetary payments to Dr. Krauss and Mr. Hornig in relation to fees incurred by those individuals
in relation to the SEC Investigation (collectively, the &ldquo;Advancement Payments&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on April 19, 2022, 180 Life demanded that AmTrust provide coverage under the Policy to 180 Life for the Advancement Payments made to
Mr. Hornig and Dr. Krauss in relation to the SEC Investigation (the &ldquo;Demand&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on May 4, 2022, AmTrust denied coverage to 180 Life in relation to the Demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on June 29, 2022, AmTrust filed a declaratory judgment action in the U.S. District Court for the Northern District of California, captioned
<I>AmTrust International Underwriters DAC v. 180 Life Sciences </I>Corp., Case No. 5:22-cv-03844-BLF, which sought a declaration that
no coverage is available to 180 Life under the Policy for the: (1) Counterclaim and Third-Party Complaint filed in the 180 Life Lawsuit;
and (2) the Advancement Payments made to Mr. Hornig and Dr. Krauss in relation to the SEC Subpoenas (the &ldquo;Coverage Action&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on September 20, 2022, 180 Life filed a Counterclaim against AmTrust in the Coverage Action, which sought coverage under the Policy for:
(1) 180 Life&rsquo;s Advancement Payments to Dr. Krauss and Mr. Hornig; and (2) the <B>Defense Costs </B>incurred by 180 Life in the
defense of Dr. Krauss&rsquo; Counterclaim and Third-Party Complaint filed in the 180 Life Lawsuit (collectively, the &ldquo;180 Life
Claims&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
on February 12, 2024, the District Court in the Coverage Action ordered that AmTrust advance to 180 Life under the Policy all <B>Defense
Costs</B> in excess of the retention threshold that 180 Life has advanced, and will advance, to Dr. Krauss and Mr. Hornig in connection
with the SEC Subpoenas, subject to AmTrust being entitled to reimbursement of the amounts advanced from 180 Life if the District Court
subsequently found no coverage for the Advancement Payments exists under the Policy in future proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
AmTrust advanced a total of $2,569,206.51 to 180 Life under the Policy pursuant to the February 12, 2024 District Court Order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
AmTrust and 180 Life have reached a settlement to resolve the Coverage Action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
while the Parties to this Agreement agree and acknowledge that this Agreement shall not be construed as an admission by any Party of
any liability, coverage, or responsibility with regard to the Policy in relation to the 180 Life Claims at issue in the Coverage Action,
the Parties now wish to, and hereby do, resolve the disputes at issue between and among them with regard to the 180 Life Claims at issue
in the Coverage Action, subject to the terms and conditions outlined in detail below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, it is stipulated and agreed by and between the Parties, in consideration of the mutual promises exchanged herein and other
valuable consideration, the receipt and sufficiency of which is hereby acknowledged, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
SETTLEMENT TERMS</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&nbsp;The
Recitals are incorporated herein as if set forth fully herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.&nbsp;Within
twenty (20) days from the &ldquo;Effective Date&rdquo; (defined below in Paragraph 18) of this Agreement, 180 Life shall pay to AmTrust
the total sum of $250,000.00 (the &ldquo;Settlement Sum&rdquo;). If the due date for payment of the Settlement Sum falls on a weekend
or a legal holiday, such payment shall be deemed to be due on the first business day thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.&nbsp;Within
three (3) business days of the Effective Date, 180 Life shall deliver to AFSI a total of 509,707 shares (such shares, the &ldquo;Subject
Shares&rdquo;) of 180 Life&rsquo;s common stock, par value $0.0001 per share (&ldquo;Common Stock&rdquo;), with an agreed upon value
of $575,000.00 (the &ldquo;Subscription Amount&rdquo;), based on the 30 trading day Volume-Weighted Average Price of the Common Stock
on the Effective Date. The Subject Shares shall have standard anti-dilution protections in place, <I>i.e</I>., the Subject Shares shall
be subject to adjustment for reverse and forward stock splits, stock dividends, and stock combinations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.&nbsp;Within
ten (10) days after delivery of both the Settlement Sum and the Subject Shares to AmTrust, the respective attorneys of record for both
AmTrust and 180 Life shall file a joint stipulated dismissal of the Coverage Action in its entirety with prejudice with the District
Court.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
RELEASE</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&nbsp;In
exchange for the mutual promises in this Agreement, including the Settlement Terms referenced in Paragraph 1 of this Agreement, 180 Life
hereby RELEASES, ACQUITS, AND FOREVER DISCHARGES AmTrust, and its past, present, or future parents, subsidiaries, affiliates, divisions,
associated entities, partners, directors, officers, members, employees, owners, shareholders, principals, agents, brokers, counselors,
representatives, attorneys, insurers, reinsurers, and all persons acting by, through, under, or in concert with any of them, and including
their respective predecessors, successors, trustees, executors, administrators, heirs, and assigns (collectively &ldquo;the AmTrust Released
Parties&rdquo;) from all past, present, and future demands, claims, actions, causes of action, controversies, suits, liabilities, costs,
expenses, attorneys&rsquo; fees, losses, judgments, settlements, promises, duties, responsibilities, agreements, covenants, damages,
declaration of rights, monetary or non-monetary relief of whatever kind or nature, whether in law or in equity, known or unknown, oral
or written, now existing or hereafter arising, contractual or extra-contractual, under warranty or otherwise, that 180 Life once had,
now has, or may have in the future have against the AmTrust Released Parties under the Policy or any other policy issued by AmTrust to
KBL and/or 180 Life arising out of or in any way relating to the following: (a) the SEC Subpoenas; (b) the SEC Investigation; (c) the
180 Life Claims; (d) the Coverage Action; (e) the Agreement; (f) all damages, costs, and/or attorney&rsquo;s fees incurred or to be incurred
by 180 Life in connection with the SEC Subpoenas; the SEC Investigation; the 180 Life Claims; the Coverage Action; and/or the Agreement;
(g) any matter alleging, based upon, arising out of, directly or indirectly resulting from, attributable to, or in any way involving
any act, failure to act, omission, misrepresentation, statement, misstatement, fact, event, transaction, occurrence, or other subject
matter set forth, alleged, embraced, encompassed, or otherwise referred to in, underlying, or related to the SEC Subpoenas; the SEC Investigation;
the 180 Life Claims; the Coverage Action; and/or the Agreement; and (h) AmTrust&rsquo;s investigation and claims handling of the SEC
Subpoenas; the SEC Investigation; the 180 Life Claims; and/or the Coverage Action under the Policy, including without limitation all
claims of &ldquo;bad faith,&rdquo; all claims of unfair business or insurance practice under any state or federal statute, all common
law claims for bad faith insurance practices or breach of the implied covenant of good faith and fair dealing, and all claims for any
alleged failure to effectuate prompt, fair, and equitable settlements of claims (collectively, the &ldquo;Released Matters&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.&nbsp;In
exchange for the mutual promises in this Agreement, AmTrust, on its own behalf and on behalf of its past, present, or future affiliates,
predecessors, successors, parents, subsidiaries, divisions, partnerships, and joint ventures, and all of the foregoing entities&rsquo;
respective past, present and future associates, representatives, owners, members, managers, estates, heirs, assigns, insurers, shareholders,
creditors, liquidators, administrators, executors, partners, principals, trustees, directors, officers, employees, committee members,
volunteers, attorneys, and agents hereby RELEASE, ACQUIT, AND FOREVER DISCHARGE 180 Life, and its past, present, or future affiliates,
predecessors, successors, parents, subsidiaries, divisions, partnerships, and joint ventures, and all of the foregoing persons and entities&rsquo;
respective past, present and future associates, representatives, owners, members, managers, estates, heirs, assigns, shareholders, creditors,
liquidators, administrators, executors, partners, principals, trustees, directors, officers, employees, committee members, volunteers,
attorneys, agents (collectively &ldquo;the 180 Life Released Parties&rdquo;) from all past, present, and future demands, claims, actions,
causes of action, controversies, suits, liabilities, costs, expenses, attorneys&rsquo; fees, losses, judgments, settlements, promises,
duties, responsibilities, agreements, covenants, damages, declaration of rights, monetary or non-monetary relief, of whatever kind or
nature, whether in law, equity, or otherwise, known or unknown, now existing or hereafter arising, arising out of or in any way relating
to the Released Matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.&nbsp;The
Released Matters are and may be pleaded as a full and complete defense to, and are and may be used as the basis for an injunction against,
prosecution of any demands, claims, actions, causes of action, controversies, suits, liabilities, costs, expenses, attorneys&rsquo; fees,
losses, judgments, settlements, promises, duties, responsibilities, agreements, covenants, damages, declaration of rights, monetary or
non-monetary relief of whatever kind or nature that seeks recovery arising directly or indirectly out of, or in any way involving or
relating to, or based upon, or in connection with any of the Released Matters. The Released Matters do not preclude any Party from enforcing
the terms and conditions of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
GOOD FAITH AND COOPERATION </B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Parties agrees to cooperate in good faith to achieve the intent and spirit of this Agreement and to do all things appropriate
or necessary, including, but not limited to, executing any documents or taking any reasonable actions in a timely and expeditious manner,
in order to effectuate all of the terms and conditions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.&nbsp;WAIVER
OF RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&nbsp;The
Parties expressly waive any and all rights they may have, under federal or state statute, contract, equity or otherwise, to assert unknown
or unsuspected claims related to the Released Matters, including, but not limited to, all rights and benefits which they now have or
may in the future have under the terms of Section 1542 of the Civil Code of the State of California or under the statute or common law
of any other jurisdiction applicable hereto which has the same or similar effect as the provisions of said Section 1542, which reads
in full as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING
THE RELEASE WHICH, IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.&nbsp;The
Parties acknowledge that they may have sustained damages, losses, fees, costs, or expenses that are presently unknown and unsuspected,
and that such damages, losses, fees, costs, or expenses they may have sustained might give rise to additional damages, losses, fees,
costs, or expenses in the future. Nevertheless, the Parties acknowledge that this Agreement has been negotiated and agreed upon in light
of such possible past, present, or future damages, losses, fees, costs, or expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.&nbsp;NO
ADMISSION OF LIABILITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
in this Agreement shall be construed as an admission of liability, fault, or coverage, or the lack of coverage under the Policy or any
other policy of insurance issued or subscribed to by AmTrust. AmTrust does not concede or agree that any coverage is afforded for the
Released Matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.&nbsp;LIMITATIONS
OF WAIVER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver
of any one breach of a provision of this Agreement shall not be deemed a waiver of any breach of any other provision, or of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.&nbsp;CONSTRUCTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Parties have reviewed and revised, or have had the opportunity to revise, this Agreement. The Parties agree that any uncertainty or ambiguity
shall not be interpreted or construed against any Party under or by any rule of interpretation providing for interpretation against the
Party who caused an uncertainty to exist or against the draftsman, and that the Agreement shall be construed as if all Parties prepared
it jointly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.&nbsp;INTEGRATED
AGREEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement constitutes the complete expression of the terms of the release between the Parties. All prior and contemporaneous agreements,
representations, and negotiations are hereby superseded. The Parties warrant and represent that no promise or representation of any kind
has been expressed or implied by the Parties released herein or by anyone acting for them, except as is expressly stated in this Agreement.
No amendment to or modification of this Agreement shall be effective unless it is in writing and signed by duly-authorized representatives
of the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.&nbsp;SETTLEMENT;
ARMS-LENGTH NEGOTIATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&nbsp;This
Agreement represents a settlement of coverage issues and is the product of arms-length negotiations. The Parties have read this Agreement
carefully and completely, have had the advice and assistance of their own independent legal counsel, and agree that this Agreement is
executed solely in reliance on each Party&rsquo;s own judgment, beliefs, and knowledge, and not on any representations or statements
of fact or opinion made by any other Party or its agents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.&nbsp;The
Parties further agree that this Agreement has been negotiated and executed in good faith and without improper influence by any person.
The Parties have informed themselves of the terms of this Agreement and understand the same, and the Parties sign this Agreement as their
own free act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.&nbsp;NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices and other communications related to this Agreement shall be in writing and shall be given (and shall be deemed to have been duly
given if so given) by hand delivery, facsimile, or email (with hard copy to be sent by overnight courier or by registered or certified
mail, postage prepaid, return receipt requested) to the respective Parties hereto as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 40pt; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: right"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            to 180 Life:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
M. Loev, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Loev Law Firm, PC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6300
West Loop South, Suite 280</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bellaire,
Texas 77401</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dloev@loevlaw.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: right"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            to AmTrust and/or AFSI:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
L. Koury, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BatesCarey
LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">191
North Wacker, Suite 2400</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chicago,
IL 60606</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dkoury@batescarey.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
addresses may be changed from time to time by mailing appropriate notice thereof to all Parties hereto by overnight courier or by certified
or registered mail (return receipt requested).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.&nbsp;CHOICE
OF LAW AND UNENFORCEABLE PARTS OF AGREEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
agreement shall be interpreted and governed in accordance with the laws of the State of California. In the event that any provision of
this Agreement is held unenforceable or invalid, such holding shall not affect the validity or enforceability of the other provisions
of this Agreement or the Agreement as a whole, but instead, the Agreement shall be construed as if it did not contain the unenforceable
or invalid part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.&nbsp;COUNTERPARTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may be executed in multiple counterparts, each of which, when so executed and delivered, shall be deemed an original, and all
of which shall constitute one Agreement. Each signature may be delivered by facsimile, PDF, or by electronic mail, which shall be treated
as an original signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.&nbsp;NO
THIRD-PARTY RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement is intended to confer rights and benefits on the Parties. Except as otherwise expressly provided herein, no person or entity
other than the Parties shall have any rights under this Agreement. The Parties warrant and represent that they are the sole owners of
the respective rights and claims relinquished by this Agreement and that, prior to entering into this Agreement, the Parties have not
sold, transferred, or assigned any rights or obligations under the Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.&nbsp;NO
CUSTOM, PRACTICE, OR COURSE OF DEALING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Party understands and agrees that the terms of this Agreement have been specifically negotiated and drafted with respect to the specific
matters dealt with herein, and that in doing so each Party has made compromises from the positions which it believes itself to be legally
entitled to assert, and no Party hereto shall be deemed to have established any custom, practice, or course of dealing which may be held
against that Party in the future by reason of that Party&rsquo;s acceptance of this Agreement or any of its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.&nbsp;AUTHORITY
OF SIGNATORIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Party and the person signing this agreement hereby warrant and represent that the person signing this Agreement is expressly authorized
and empowered by the Party on whose behalf the person&rsquo;s signature appears to bind that Party to each of the obligations set forth
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.
180 LIFE&rsquo;S REPRESENTATIONS AND WARRANTIES; REGISTRATION RIGHTS; INDEMNIFICATION</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&nbsp;180
Life represents and warrants to AmTrust that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180
                                            Life is unaware of any other <B>Claims</B> or potential <B>Claims</B> under the Policy other
                                            than the Released Matters that have already been noticed to AmTrust under the Policy.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180
                                            Life has the requisite corporate power and authority to enter into and to consummate the
                                            transactions contemplated by this Agreement. This Agreement has been duly executed by 180
                                            Life and, when delivered in accordance with the terms hereof, will constitute the valid and
                                            binding obligation of 180 Life, enforceable against 180 Life in accordance with its terms</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180
                                            Life is an entity duly incorporated or otherwise organized, validly existing, and in good
                                            standing under the laws of the jurisdiction of its incorporation, with the requisite power
                                            and authority to own and use its properties and assets and to carry on its business as currently
                                            conducted.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            execution, delivery and performance by 180 Life of this Agreement, the issuance and sale
                                            of the Subject Shares and the consummation by it of the transactions contemplated hereby
                                            and thereby do not and will not (i) conflict with or violate any provision of 180 Life&rsquo;s
                                            certificate or articles of incorporation, bylaws or other organizational or charter documents,
                                            or (ii) conflict with, or constitute a default (or an event that with notice or lapse of
                                            time or both would become a default) under, result in the creation of any lien or other encumbrance
                                            upon any of the properties or assets of 180 Life or any subsidiary of 180 Life, or give to
                                            others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration
                                            or cancellation (with or without notice, lapse of time or both) of, any agreement, credit
                                            facility, debt or other instrument (evidencing a 180 Life or a subsidiary of 180 Life debt
                                            or otherwise) or other understanding to which 180 Life or any 180 Life subsidiary is a party
                                            or by which any property or asset of 180 Life or any 180 Life subsidiary is bound or affected,
                                            or (iii) conflict with or result in a violation of any law, rule (including the rules of
                                            The Nasdaq Stock Market LLC (&ldquo;Nasdaq&rdquo;)), regulation, order, judgment, injunction,
                                            decree or other restriction of any court or governmental authority to which 180 Life or a
                                            180 Life subsidiary is subject (including federal and state securities laws and regulations),
                                            or by which any property or asset of 180 Life or a 180 Life subsidiary is bound or affected.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180
                                            Life is not required to obtain any consent, waiver, authorization or order of, give any notice
                                            to, or make any filing or registration with, any court or other federal, state, local or
                                            other governmental authority or other person or entity in connection with the execution,
                                            delivery and performance by 180 Life of this Agreement, other than: (i) the filing with the
                                            SEC of the Resale Registration Statement (as defined below), (ii) the notice and/or application(s)
                                            to Nasdaq for the listing of the Subject Shares for trading thereon in the time and manner
                                            required thereby, and (iii) such filings as are required to be made under applicable state
                                            securities laws.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180
                                            Life is not required to obtain any approval of its stockholders of, or submit to a vote of
                                            its stockholders for, the issuance of the Subject Shares or 180 Life entering into this Agreement
                                            (including but not limited to, pursuant to Nasdaq Listing Rule 5635).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Subject Shares are duly authorized and, when issued, will be duly and validly issued, fully
                                            paid, and non-assessable, free and clear of all liens and other encumbrances.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            of the Effective Date, trading in the Common Stock has not been suspended by the SEC or Nasdaq,
                                            and 180 Life does not anticipate that trading in the Common Stock will be suspended by the
                                            SEC or Nasdaq in the 12 months following the Effective Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180
                                            Life has filed all reports, schedules, forms, statements and other documents required to
                                            be filed by 180 Life under the Securities Act and the Exchange Act, including pursuant to
                                            Section 13(a) or 15(d) thereof, for the 2 years preceding the Effective Date (or such shorter
                                            period as 180 Life was required by law or regulation to file such material) (the foregoing
                                            materials, including the exhibits thereto and documents incorporated by reference therein,
                                            being collectively referred to herein as the &ldquo;SEC Reports&rdquo;), and, for the 1 year
                                            preceding the Effective Date, has filed all such SEC Reports on a timely basis or has received
                                            a valid extension of such time of filing and has filed any such SEC Reports prior to the
                                            expiration of any such extension. As of their respective dates, the SEC Reports complied
                                            in all material respects with the requirements of the Securities Act and the Exchange Act,
                                            as applicable, and none of the SEC Reports, when filed, contained any untrue statement of
                                            a material fact or omitted to state a material fact required to be stated therein or necessary
                                            in order to make the statements therein, in the light of the circumstances under which they
                                            were made, not misleading, subject to amendments thereto. The financial statements of 180
                                            Life included in the SEC Reports comply in all material respects with applicable accounting
                                            requirements and the rules and regulations of the SEC with respect thereto as in effect at
                                            the time of filing. Such financial statements have been prepared in accordance with United
                                            States generally accepted accounting principles applied on a consistent basis during the
                                            periods involved (&ldquo;GAAP&rdquo;), except as may be otherwise specified in such financial
                                            statements or the notes thereto and except that unaudited financial statements may not contain
                                            all footnotes required by GAAP, and fairly present in all material respects the financial
                                            position of 180 Life and its consolidated subsidiaries as of and for the dates thereof and
                                            the results of operations and cash flows for the periods then ended. 180 Life has not disclosed
                                            any material, non-public information (&ldquo;MNPI&rdquo;) to AmTrust or its agents or counsel.
                                            180 Life has not entered into any definitive agreements for which the entry into or the existence
                                            of such agreements constitute MNPI, except as disclosed in the SEC Reports as of the Effective
                                            Date.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180
                                            Life has not filed for, or otherwise been subject to, reorganization or liquidation under
                                            the bankruptcy or reorganization laws of any jurisdiction. 180 Life has no knowledge of any
                                            facts or circumstances which lead it to believe that it will file for reorganization or liquidation
                                            under the bankruptcy or reorganization laws of any jurisdiction, or otherwise cause 180 Life
                                            to be subject to reorganization or liquidation under the bankruptcy or reorganizations laws
                                            of any jurisdiction, within 1 year from the Effective Date. All outstanding secured and unsecured
                                            Indebtedness (as defined below) of 180 Life or any subsidiary, or for which 180 Life or any
                                            subsidiary has commitments is set forth in the SEC Reports. For the purposes of this Agreement,
                                            &ldquo;Indebtedness&rdquo; means (A) any liabilities for borrowed money or amounts owed,
                                            (B) all guaranties, endorsements and other contingent obligations in respect of indebtedness
                                            of others, whether or not the same are or should be reflected in 180 Life&rsquo;s consolidated
                                            balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments
                                            for deposit or collection or similar transactions in the ordinary course of business, and
                                            (C) the present value of any lease payments in excess of $25,000 due under leases required
                                            to be capitalized in accordance with GAAP. Except as set forth in the SEC Reports, neither
                                            180 Life nor any subsidiary is in default with respect to any Indebtedness.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.&nbsp;<B>REGISTRATION
RIGHTS</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180
                                            Life agrees to use its commercially reasonable efforts to file with the SEC within 45 days
                                            of the Effective Date, a registration statement on Form S-1 (or, if available, Form S-3)
                                            providing for the resale of the Subject Shares by AmTrust (the &ldquo;Resale Registration
                                            Statement&rdquo;). 180 Life shall use commercially reasonable efforts to cause the Resale
                                            Registration Statement to become effective within 60 calendar days following the Effective
                                            Date and to keep the Resale Registration Statement effective at all times (including filing
                                            of additional Resale Registration Statements, if necessary) until the date that AmTrust no
                                            longer holds any Subject Shares, <I>provided, however</I>, that if 180 Life is notified by
                                            the SEC that the Resale Registration Statements will not be reviewed by the SEC then 180
                                            Life shall cause such Registration Statement to be declared effective by SEC no later than
                                            the 3rd business day following the date on which 180 Life is so notified if such date precedes
                                            the dates otherwise required above. Notwithstanding the above, a Rule 144 legal opinion shall
                                            be provided at 180 Life&rsquo;s expense, at the request of AmTrust, if needed, to allow the
                                            Subject Shares to be sold after six (6) months under Rule 144, to the extent available. In
                                            addition to, 180 Life shall pay all of its costs, fees and expenses incident to the performance
                                            of or compliance with, all matters relating to the Resale Registration Statement including
                                            but not limited to its filing, registration, effectiveness, and any necessary updates, supplements,
                                            or amendments. For the sake of clarity, 180 Life shall not be responsible for, and shall
                                            not be required to pay for or reimburse AmTrust or its legal counsel for, any expenses incurred
                                            or paid by such persons relating to the Resale Registration Statement. Notwithstanding anything
                                            to the contrary contained herein, in no event shall 180 Life be permitted to name AmTrust
                                            or any affiliate of AmTrust as an underwriter without the prior written consent of AmTrust.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            180 Life fails to (A) file the Resale Registration Statement within the time specified in
                                            subsection (i), (B) cause such Registration Statement to become effective within 105 days
                                            of the Effective Date, or (C) maintain the effectiveness of the Resale Registration Statement
                                            as provided in subsection (i) (each, a &ldquo;Registration Statement Failure Event&rdquo;),
                                            then, in addition to any other rights AmTrust may have hereunder or under applicable law,
                                            on each such Registration Statement Failure Event and on each monthly anniversary of each
                                            such Registration Statement Failure Event (if the applicable Registration Statement Failure
                                            Event shall not have been cured by such date) until the applicable Registration Statement
                                            Failure Event is cured, 180 Life shall pay to AmTrust an amount in cash, as liquidated damages
                                            and not as a penalty, equal to the product of 3.0% <I>multiplied by</I> the aggregate Subscription
                                            Amount paid by AmTrust pursuant to this Agreement with respect to Subject Shares held by
                                            AmTrust and its affiliates on the date of the Registration Statement Failure Event or monthly
                                            anniversary, as applicable. The parties agree that the maximum aggregate liquidated damages
                                            payable under this Agreement pursuant to this Section 16.B.(ii) with respect to all Registration
                                            Statement Failure Event shall be 33.0% of the Subscription Amount. The liquidated damages
                                            described in this Section 16.B.(ii) shall be the sole damages payable to AmTrust due to the
                                            occurrence of a Registration Statement Failure Event pursuant to this Section 16.B.(ii),
                                            but shall not preclude any damages or other relief from 180 Life&rsquo;s breach of any other
                                            Section of this Agreement including Section 16.B.(i).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
                                            less than 3 business days prior to the filing of the Resale Registration Statement and not
                                            less than 2 business days prior to the filing of any related Prospectus or any amendment
                                            or supplement thereto (including any document that would be incorporated or deemed to be
                                            incorporated therein by reference), except for the final prospectus, which date shall be
                                            1 business day prior to filing, 180 Life shall furnish to AmTrust copies of all such documents
                                            proposed to be filed, which documents (other than those incorporated or deemed to be incorporated
                                            by reference) will be subject to the review of AmTrust.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            receipt of written notice from 180 Life that the Resale Registration Statement or Prospectus
                                            contains a Misstatement (defined below) or that the Resale Registration Statement or Prospectus
                                            can no longer be relied upon or used, AmTrust agrees to discontinue disposition of the Subject
                                            Shares under the Registration Statement and Prospectus until it has received copies of a
                                            supplemented or amended Prospectus correcting the Misstatement (it being understood that
                                            180 Life hereby covenants to prepare and file such supplement or amendment as soon as practicable
                                            after the time of such notice), or until it is advised in writing by 180 Life that the use
                                            of the Prospectus may be resumed, <I>provided, however</I>, that such suspension shall be
                                            for the shortest period of time possible for 180 Life to correct the Misstatement and in
                                            no event may 180 Life suspend use of the Registration Statement or Prospectus for more than
                                            15 days in any 12-month period. &ldquo;Misstatement&rdquo; shall mean an untrue statement
                                            of a material fact or an omission to state a material fact required to be stated in the Resale
                                            Registration Statement or Prospectus, or necessary to make the statements in the Resale Registration
                                            Statement or Prospectus (in the light of the circumstances under which they were made) not
                                            misleading.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
                                            3 business days of the earlier of the Resale Registration Statement being declared effective
                                            by the SEC (the &ldquo;Legend Removal Deadline&rdquo;) or the Subject Shares being freely
                                            tradeable pursuant to Rule 144 under the Securities Act, 180 Life shall cause the Subject
                                            Shares Legend to be removed from all the Subject Shares and shall work with 180 Life&rsquo;s
                                            transfer agent to ensure the same. All costs related to the removal of the Subject Shares
                                            Legend shall be paid by 180 Life.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180
                                            Life shall use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal
                                            of (i) any order stopping or suspending the effectiveness of the Resale Registration Statement,
                                            or (ii) any suspension of the qualification (or exemption from qualification) of any of the
                                            Subject Shares for sale in any jurisdiction, at the earliest practicable moment. 180 Life
                                            shall file any and all necessary &ldquo;blue sky&rdquo; filings to obtain registration or
                                            exemption, as applicable, of the Subject Shares in all relevant jurisdictions at all times,
                                            with all costs thereto related to be borne solely 180 Life.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.&nbsp;180
Life agrees to indemnify and hold harmless AmTrust in the event that any individual or entity who is not a Party to the Agreement objects
to and/or contests the Agreement&rsquo;s terms and conditions, including with respect to 180 Life&rsquo;s payment of the Settlement Sum
and/or 180 Life&rsquo;s issuance of the Subject Shares to AmTrust.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.
AMTRUST&rsquo;S REPRESENTATIONS AND WARRANTIES </B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&nbsp;AmTrust
and/or AFSI, as identified below, confirms and acknowledges to 180 Life that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmTrust
                                            and AFSI have the requisite corporate power and authority to enter into and to consummate
                                            the transactions contemplated by this Agreement. This Agreement has been duly executed by
                                            AmTrust and AFSI, and, when delivered in accordance with the terms hereof, will constitute
                                            the valid and binding obligation of AmTrust and AFSI, enforceable against AmTrust and AFSI
                                            in accordance with its terms.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmTrust
                                            and AFSI are entities duly incorporated or otherwise organized, validly existing, and in
                                            good standing under the laws of the jurisdiction of its incorporation or organization, with
                                            the requisite power and authority to own and use their properties and assets and to carry
                                            on their business as currently conducted.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            execution, delivery and performance by AmTrust and AFSI of this Agreement and the consummation
                                            by them of the transactions contemplated hereby and thereby do not and will not (i) conflict
                                            with or violate any provision of AmTrust&rsquo;s and AFSI&rsquo;s certificate or articles
                                            of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with,
                                            or constitute a default (or an event that with notice or lapse of time or both would become
                                            a default) under any agreement or understanding to which AmTrust and AFSI are a party, or
                                            (iii) conflict with or result in a violation of any law, rule, regulation, order, judgment,
                                            injunction, decree or other restriction of any court or governmental authority to which AmTrust
                                            and AFSI are subject.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AFSI
                                            will be acquiring the Subject Shares, for its own account, for investment purposes only and
                                            not with a view to, or for sale in connection with, a distribution, as that term is used
                                            in Section 2(a)(11) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;),
                                            in a manner which would require registration under the Securities Act or any state securities
                                            laws, except pursuant to the Resale Registration Statement or as otherwise registered or
                                            exempted from registration. AFSI can bear the economic risk of investment in the Subject
                                            Shares, has knowledge and experience in financial business matters, is capable of managing
                                            the risk of investment in the Subject Shares and is an &ldquo;accredited investor&rdquo;
                                            as defined in Regulation D under the Securities Act. AFSI recognizes that the Subject Shares
                                            have not been registered under the Securities Act, nor under the securities laws of any state
                                            and, therefore, cannot be resold unless the resale of the Subject Shares is registered under
                                            the Securities Act or unless an exemption from registration is available. AFSI has carefully
                                            considered and has, to the extent it believes such discussion necessary, discussed with its
                                            professional, legal, tax and financial advisors, the suitability of an investment in the
                                            Subject Shares for its particular tax and financial situation and its respective advisers,
                                            if such advisors were deemed necessary, have determined that the Subject Shares are a suitable
                                            investment for it. AFSI has not been offered the Subject Shares by any form of general solicitation
                                            or advertising, including, but not limited to, advertisements, articles, notices or other
                                            communications published in any newspaper, magazine, or other similar media or television
                                            or radio broadcast or any seminar or meeting where, to AFSI&rsquo;s knowledge, those individuals
                                            that have attended have been invited by any such or similar means of general solicitation
                                            or advertising. AFSI has had an opportunity to ask questions of and receive satisfactory
                                            answers from 180 Life, or persons acting on behalf of 180 Life, concerning the terms and
                                            conditions of the Subject Shares and 180 Life, and all such questions have been answered
                                            to the full satisfaction of AFSI. Neither 180 Life, nor any other party, has supplied AFSI
                                            any information regarding the Subject Shares or an investment in the Subject Shares other
                                            than as contained in this Agreement, and AFSI is relying on its own investigation and evaluation
                                            of 180 Life and the Securities and not on any other information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AFSI
                                            acknowledges that it is a sophisticated investor capable of assessing and assuming investment
                                            risks with respect to securities, including securities such as the Subject Shares, and further
                                            acknowledges that 180 Life is entering into this Agreement with AmTrust and AFSI in reliance
                                            on this acknowledgment and with AmTrust&rsquo;s and AFSI&rsquo;s understanding, acknowledgment
                                            and agreement that 180 Life may be privy to MNPI regarding 180 Life, which MNPI may be material
                                            to a reasonable investor, such as AmTrust and AFSI, when making investment disposition decisions,
                                            including the decision to enter into this Agreement, and AmTrust&rsquo;s and AFSI&rsquo;s
                                            decision to enter into the Agreement is being made with full recognition and acknowledgment
                                            that 180 Life may be privy to MNPI.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AFSI
                                            understands and agrees that a legend (the &ldquo;Subject Shares Legend&rdquo;) has been or
                                            will be placed on any certificate(s) or other document(s) evidencing the Subject Shares in
                                            substantially the following form:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES
ACT. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS (I) THEY SHALL
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED AND ANY APPLICABLE STATE SECURITIES ACT, OR (II) THE CORPORATION SHALL
HAVE BEEN FURNISHED WITH AN OPINION OF COUNSEL, SATISFACTORY TO COUNSEL FOR THE CORPORATION, THAT REGISTRATION IS NOT REQUIRED UNDER
ANY SUCH ACTS.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AFSI
                                            will be responsible for complying with the applicable provisions of the Securities Act and
                                            the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), and the
                                            rules and regulations thereunder promulgated, including, without limitation, Regulation M,
                                            as and if applicable to AFSI in connection with resales of the Subject Shares under the Resale
                                            Registration Statement and prospectus included therein (the &ldquo;Prospectus&rdquo;). AFSI
                                            agrees not to sell any of the Subject Shares pursuant to a Prospectus or Resale Registration
                                            Statement unless they are sold in compliance with the plan of distribution set forth therein.
                                            AFSI agrees to comply with the prospectus delivery requirements of the Securities Act and
                                            Exchange Act in connection with the sale of the Subject Shares under the Prospectus and Resale
                                            Registration Statement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AFSI
                                            agrees, if reasonably requested in writing, to represent to 180 Life the total number of
                                            shares of common stock beneficially owned by AFSI, the person or persons with voting and
                                            dispositive control over AFSI, and such other information as may be reasonably requested
                                            by 180 Life or its counsel, in order for 180 Life to make required disclosures in the Resale
                                            Registration Statement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18.&nbsp;EFFECTIVE
DATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement shall be effective up execution of this Agreement by all Parties, which date shall be known as the &ldquo;Effective Date&rdquo;
of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties have signed this Agreement by their respective authorized officers, representatives, or counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: 4/4/2025</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180 Life Sciences Corp.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Blair Jordan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: 4/5/2025</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmTrust International Underwriters DAC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ariel Gorelik</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AmTrust Financial Services, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    4/5/2025</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ariel Gorelik</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COO</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>atnf-20250406.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qRZo7xRiXhun8uNbXQsSaaA2aPtypR12Ykxs2t5HSk6jykjuTgC9yFljthWQRAM -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ATNF="http://180lifesciences.com/20250406" elementFormDefault="qualified" targetNamespace="http://180lifesciences.com/20250406">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://180lifesciences.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="atnf-20250406_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="atnf-20250406_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="atnf-20250406_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="ATNF_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATNF_WarrantsToPurchaseSharesOfCommonStockMember" name="WarrantsToPurchaseSharesOfCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>atnf-20250406_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://180lifesciences.com/role/Cover" xlink:href="atnf-20250406.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://180lifesciences.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atnf-20250406.xsd#ATNF_CommonStockParValue0.0001PerShareMember" xlink:label="loc_ATNFCommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFCommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atnf-20250406.xsd#ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:label="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>atnf-20250406_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atnf-20250406.xsd#ATNF_CommonStockParValue0.0001PerShareMember" xlink:label="ATNF_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATNF_CommonStockParValue0.0001PerShareMember" xlink:to="ATNF_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATNF_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="atnf-20250406.xsd#ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:label="ATNF_WarrantsToPurchaseSharesOfCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:to="ATNF_WarrantsToPurchaseSharesOfCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATNF_WarrantsToPurchaseSharesOfCommonStockMember_lbl" xml:lang="en-US">Warrants to purchase shares of Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>atnf-20250406_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://180lifesciences.com/role/Cover" xlink:href="atnf-20250406.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://180lifesciences.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atnf-20250406.xsd#ATNF_CommonStockParValue0.0001PerShareMember" xlink:label="loc_ATNFCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atnf-20250406.xsd#ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:label="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  06,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">180 LIFE SCIENCES CORP.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001690080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-1890354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3000 El Camino Real<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Bldg. 4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">507-0669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATNF_CommonStockParValue0.0001PerShareMember', window );">Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATNF<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATNF_WarrantsToPurchaseSharesOfCommonStockMember', window );">Warrants to purchase shares of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to purchase shares of Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATNFW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATNF_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATNF_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATNF_WarrantsToPurchaseSharesOfCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATNF_WarrantsToPurchaseSharesOfCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -)#B5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( -)#B5I&JF5Y[P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DE%+PS 0Q[^*Y+V]M-6!H<N+8T\*@@/%MY#<
MMF"3AN2DW;<WK5N'Z ?P,7?__.YW<*T.0O<1GV,?,)+%=#.ZSB>APYH=B8(
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M%E(;L,&_17IR\M8H]MLMVL78RM[AXJ:?YW ,B]G3*+A MX,65]DB7-S9[V0
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M',$8  <,2=/^/7CW/DK&]U1R^8^P^0E02P,$%     @ TD.)6I>*NQS
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M7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ TD.)6B0>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #20XE:1JIE>>\    K @  $0
M            @ '#    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #2
M0XE:F5R<(Q &  "<)P  $P              @ 'A 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( -)#B5JLVO-2O 0  '04   8
M  " @2((  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #2
M0XE:X/0ZB:H"   P#   #0              @ $4#0  >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( -)#B5J7BKL<P    !,"   +              "  >D/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( -)#B5JJQ"(6,P$  "("   /
M          "  =(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #20XE:
M)!Z;HJT   #X 0  &@              @ $R$@  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " #20XE:99!YDAD!  #/ P  $P
M        @ $7$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(  !A%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0237417-8k_180life.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://180lifesciences.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>atnf-20250406.xsd</File>
    <File>atnf-20250406_def.xml</File>
    <File>atnf-20250406_lab.xml</File>
    <File>atnf-20250406_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0237417-8k_180life.htm">ea0237417-8k_180life.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0237417-8k_180life.htm": {
   "nsprefix": "ATNF",
   "nsuri": "http://180lifesciences.com/20250406",
   "dts": {
    "schema": {
     "local": [
      "atnf-20250406.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "atnf-20250406_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "atnf-20250406_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "atnf-20250406_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0237417-8k_180life.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 27
   },
   "report": {
    "R1": {
     "role": "http://180lifesciences.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-04-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0237417-8k_180life.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-04-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0237417-8k_180life.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "auth_ref": []
    },
    "ATNF_CommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://180lifesciences.com/20250406",
     "localname": "CommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ATNF_WarrantsToPurchaseSharesOfCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://180lifesciences.com/20250406",
     "localname": "WarrantsToPurchaseSharesOfCommonStockMember",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to purchase shares of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://180lifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001213900-25-030101-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-030101-xbrl.zip
M4$L#!!0    ( -)#B5K22*(RS@,  .D.   1    871N9BTR,#(U,#0P-BYX
M<V2]5UMSVCH0?C\S_0^JWWV!7-JXT$XF&7J825(*M$W/2T?8,BC(DBO)@?S[
MKGP+8'"!GI0G>?5]>Y%V5TOGPS)FZ)%(107O6BW'LQ#A@0@IGW:M+R/[<G35
M[UOHP_M7_R#X=5[;-NI1PD(?78O [O-(O$-W."8^^D@XD5@+^0Y]Q2PU$M&C
MC$AT)>*$$4U@([?DHW/'FR#;WD/M5\)#(;\,^Y7:F=:)\EUWL5@X7#SBA9!S
MY00BWD_A2&.=JDJ;M_2*WW[T6ZJ"BNS^'/XGWBR']'Z6\K?IW>3^LQIA?-G&
M _V4#%OM[_.E:NNS?T?S\X>G^4,ZGEY=//78@YY]^SR\O,U-=E0P(S%&<!=<
M=2T37Q'>XL01<NJV/:_EWM_>C#*<E0/]):-\O@W>NKBX<+/=$EI#+B>2E:I/
M7+,]P8I4FF&7-N I5QKS8 T?ZHJP"CYS\\TU*-T*/<^AM(2&9 .G2.!,Q:,+
M&X!OGY; 5-E3C),*'&$UR906&VM@)74=",)-D T72-16:+ZU1@BUW""LG1IL
MNV;;<-JV=V*?M$KFY?BN5Y%:;SU&(Z(""E5(LJ0VE#/OU#N'RF0D)ESWA(RO
M2813!I'\3#$P* DMI+&<$FVR5"4X(/LI+3,><RZ@,* X"XF1)0F%S*\$(#*9
MXDO!R!BB068!E=EHR6#<*P$]QD(T[%KY<D5GJ34D$>4T\Z HR!:R3?FE)FA8
M9LR.NPFN:TH5"3_Q]]DZD40!/8OL!@0%OX T<P/,@I0=17WVKXE9R,OSK!UT
M69=#$J&LGGV31%U+4=-0K4(VDR3J6ECSR"ZO]0>$[4!^E1!CH:&>LSO:/*G"
M<*D"RZ"FI=9O0(E(B-04RF.EJ>2N4VWH@Q4SR-A1%G+_Q\@9GAP:.5 (>\&0
M;XS^EX@5LNS06-<3\X4"OJZ,U*/NN.MM!;XW6T\' A=2(UYK94U/4?Z(WH@@
M4]5 ,5]VR;.-R&ZUH2,[2Q4^>WJ($\_'<)@3)>\()W8\B-OLJUUPLS#)=+JO
MT1T/:Z/1K1R7,*U*R=$NK#[#?^!#IN8@)W[_MN]RYW?,[%L=E02!2+F63X<D
MPBJE_#CN-IX'J/TNHL3GEV!FJF/-'I$%=>,[4Z 8N;+)Q4QJ/^"_3"SX2(M@
M/L R^QO@.696&1 YFF%);DD\,;..\=I,._O"*8-GR#1/+5/33\T([D.?I2(<
M9\]!F,HL*ACT\N]RY/1#$6/*^YK$!@FGD$X4=.+4H#]*D<)DG*NC &D*[AN6
M$G.MQF*0RF &G2GS47V*5N)8#_ PRM\-LN/F^0#+7U!+ P04    " #20XE:
M,H,$E $)  "4:   %0   &%T;F8M,C R-3 T,#9?9&5F+GAM;-5=;5/CMA;^
MWIG['WS3SR$OP+9+EW:R6>ADNKM0DN[V]@NCV$JB09$828;DWU_)+\&.=6R'
M@K#Y (YSCO2<YY$E'5LR'W[;K*GW@(4DG)UW!D?]CH>9SP/"EN>=OZ;=T70\
MF70\J1 +$.4,GW<8[_SVZW]^\/3/A_]VN]XEP30X\SYQOSMA"_Z+]Q6M\9GW
M.V98(,7%+]XW1$-SAE\2BH4WYNM[BA767\05GWGOCOISK]NM4>PWS (N_KJ9
M[(I=*74OSWJ]Q\?'(\8?T",7=_+(Y^MZ!4X54J'<E=;?]).?V/T#)>SNS/R:
M(XD]31>39QM)SCNFWJ3:Q^,C+I:]8;\_Z/W]Y?/47^$UZA)F:/-Q)_4RI=C\
M!N_?O^]%WZ:F!<O-7-"TCN->"F=7LOXV4#N'K/%I+_XR:TI*BLZ EN1,1I%\
MYCY240.I1.2!%N93-S7KFE/=P;![/#C:R*"3ZA21+3C%-WCAF;]:Z%VM@Y_[
ME"RP](ENHCB2N&=L>F.N6[ &''FO!%Z<=Y!B"UW)\+1_TG]GJO@Q9Z2V][HE
M2V(:8L?KY:I'PD\1V(RSM0#!IIR;*$^CRE>Z".&'<]P-R!HST^@[7E)1-L1=
M*82IGC;M)38]:P&OCWM763?@:T0.!%WT=H XJJF[QNNYD?L@N'G7U\>**#T,
M8>3P^K@85Z-#H:4^3MLD7J"0JF<WRM0]CUF?)HR8_NZS_IC#C3=*#S\X2)&;
M @_LGA11QB<98P9>UPQ(H8:D]&%LF:!)\5#NYT!0TQMS461/IF$OD)Q'L8>R
MNT3H7O,X/.EAJF1ZQG2-)Q&;R8E;,PQB T,'C2?Z4*854#3'-*KV-C&VV?;>
M%O4,S9\:5 GBQ&X?[9/F(Y'B3AI,S:LR;J5G/F=*MY(+&M6F6SI>FH,4V4+P
M=265"6V\-((LMQI(Q^,BP$)/X?I/6"B7.#CO*!%:0G8LT)@B*:\64\7]N]&&
MU&E=19<7E<TZI%;)E&<?D B*U:+66^F2A?@I&9PA06RV+ZI$<9Y0)0/(,*]$
M#DDQ[+=3B]N!!?A+R9&.D/^V=WNV7E%TD&3'SY6LF!V,9E\O;W5BNN8LJOT:
MB2@A[!^94?H:B^D*"?PEF1H6U#'N-;U?0:_\O!70HN1:X,\+ NS4GMNK ;)\
M1T(@IN2,7X?"7^GT,4*B@\F@+97F@!)N;?U 8^0Y-!"PLWN1@4=B_VC)'WH!
M)G$_IP^>NC?]X3:=V\YTB19MM$G6XO;D;;BOGH39@$+<OL@X4DWM2(,)#*!+
MBI9V;G,FC2:WB/159TP'L/M))W2"W*O,[! @.6/9#J[W 8.=A=N^X@8OB50B
MNN.X"ZB\\["Z-%J$:N3@I,>M&B/&0D1O\#T7%2)D+5O!?0$P1/F)6\K_#)%0
M6-!M'=;WC%M!O TSQ/VIXXF*GE[)B*HZY.];MX)]*VB(_G=NZ9^N,*7F^2!B
MM5I_T;X5$@"P(1%^>CL1+A[,1$&'5E^'G4OKI,@CA]3XV:T:.O$F/- QB1HZ
M[!FW0@$;9HC[]V_!_04+ZC*?F+:(]RSBLF<*+FF_)-)'-,9WJ<_9'A9D BF8
MMX)^.^H7OZ?VKR3X'T:BM@ [XQ;1G\<,DN\H QZ'0N2@E?8\D'6CZ2\%#?+O
M*.>]8(JHK5FD]C4$[B9KLWVK1O-M!0OR["C1C4&EMSZ8,@OQRKC.6[: ;PM@
MD'-'"6X,;*SA"T0G+,";/_"VC/0]TQ:P;D,,TNXHL8V170NR1F([)7YUQ[)O
MVP+BK9!!YAUELS&T&=I, AT$69!X#6NU (!+"W0H0P[*X2B=C1%.F,_%/<_<
M[Q[S4%^UVS$/2H> 4L<62%.-'Q3(4<X;XQP%@<!2)G],7(,R62SF+1 #0@T^
M '.4_T+HAH=),&RE!,-R"1SEOQ"ZX\,D.&ZE!,?E$CC*@G/HQOKP2LSX(_#T
M'3!N#_U[F$'RG:; ";8HFBMQ+?@#B;<$52FPY]$>&6S 02V<ILEI.XFG"W6N
M@MBR/=QG 8.<.TV3$V#77"I$_R'W5;-3FWU[^"_"!E5PE#4G+<+<1H&67>5,
M&LUU$2E(KZ/4V(PY(X$1W*RS%LTF=Q\HR*VC//<S-T]U5IR5WD/>MVHTQU:P
M(,^NTE6S%4^"W</NZT8SFT<)4?KL;0X'4OI=$*7QF)7D(4ON( %/_JRFC:8:
M1@S2[BCEG')*?,T06W[1<0B"J)WSHEVC"0?@@FP[RBZO!39MP&S1C1;#F?V\
MXFJQ@'IJV+[1[%? !E5PE&;NP9M(&6)QJ!8%KS8I8@</ZN(HY9QB/]0=Y78P
MG,_,1G6@)]JS:C3O5K @SX[2S*]\)I!YR<YTNYYS"F_AL1@VFFT(+TBXHXPR
MA\I.=<ZDT207D8+T.LHHTXOL8N.O$%MB>$6'S;+19(. 0<X=99I/'=NR5E^]
M;%-?O:S15SO*-%-0\4)]?=U=S2E9(GA'8(E#*]B'<$-"V&)Z#2'B_5KFW6UB
M':&ZU =V":RFC28?1@S2[FHK;!@0A8,8X"5AB/DZF=L%!=PAJ/)JMAAUP(.Z
M.'U.^AU3^@?CCVR*D>0,!W%B4?:T G!IM"+5R$$YG#XY_<9IR!02T9); 5P;
M5M,6T&]##-+N]"%ILJQ\-W+%+_4L8]_NT0(12H"#6CA]>#IA"@OD*_* /R&%
M$KQE6M@]6J!%"7!0"Z<+CZ,+=:SC6?+RM0,YPQ8P7\0+$NYTO?%TC2C]&$H=
M@"SM?W*&+2"\B!<DW.F*XHLU%DO=#?XN^*-:)1MYRXBW.K1  !@W*(33E<,7
MFZ<7"\2[&DM5*%BW00([:(C_4\?;9D>^;Y::Q',"%B !* #;-UJ#"MB@"H[2
MY"NUPB([*XN@F6#*%H)4>35:D5K@05V<ILG9USR4#LL9NT9S#\ %V7::!5^'
M<TK\2\I1Z;P_8]8"KO?1@E0[S7P_(G8GPGOE;Z\%]S$V#X;D[IJLD7S5*J %
M\M2/ Q3.[5;<IQ=V)N_P#%7T;U8TVM(;%R5^+9"I$CZHCN-74<FG+7LX^+B]
MP0LLS.*-&=ZHC[JBN_+)5:5[H[4Z+ I0LDSJ_:&W%Z"N_DY_EYPWO\P_AM%G
M_@]02P,$%     @ TD.)6LG\!Q3Q"P  $Y   !4   !A=&YF+3(P,C4P-# V
M7VQA8BYX;6S-G>]OV[@9Q]\/V/_ >7NQ 76<'[<#FFOOD*;)(;@TR6JWW788
M"EJB'2$R:5!RXOSWXP])EB@^DISV2/9%ZTK?A_I2_)BD9/'1FU^VJQ0]$IXE
MC+X='1T<CA"A$8L3NGP[^C0=GTW/KZY&*,LQC7'**'D[HFSTR\]__A,2?][\
M93Q&EPE)XU/TGD7C*[I@/Z$;O"*GZ%=""<<YXS^ASSC=R"WL,DD)1^=LM4Y)
M3L0.?>!3]./!X1R-QP.*_4QHS/BGCU=5L?=YOLY.)Y.GIZ<#RA[Q$^,/V4'$
M5L,*G.8XWV15:8?;P^*/#G^3)O3A5/XUQQE!XG31['2;)6]'\KC%89].#AA?
M3HX/#X\F__YP/8WNR0J/$RI/6T1&990LQ19W]/KUZXG:6TI;RNV<I^4Q3B:E
MG:IDL3?IT-><9,EIINQ=LPCGJM5[#X- A?S?N)2-Y:;QT?'XY.A@F\6C\N2K
M,\A92CZ2!5+5/,V?UX*D+)$@C(IM]YPL[&92SB<R?D+)$N<DE@=Z+0]T]*,\
MT%^+S==X3M(1DDK!!UBOUXVRBJ"):[-WA"<LOJ O<VU&>[(OOCL\_X8*U..=
M5V'&<IR^R'P]TKGM&_*R,[Z+<W^F13=/7G:F:Y%_B.V\;7GOTVL_KZG<>"T^
M-2R2;2X&,!*7)F41'3VP.H(:&(JRJ])9U"@WE;TYX^VZRY%1E;G V5P5O,G&
M2XS7X@#'/TQ(FF?EEK'<HDY"L>&K'!O)BM#\/,59=KN8YBQZ.-LF67D<5<FW
MHP'ZB5D!&7G&RUI@'O6<BD(QB9@8R-;Y.-4G78<O.%L-LE&<,S9 _#6=5^7K
MDRPL !5IR#C)V(9'9*\VKM=FZ%DM'*Y2$2'G:X2./TU'/RL98@NDA.AW*?W?
MF\FNZ)>PA'.ZD(#\\_"'0_U-.9O=7'X5<[D5H^I =YBK.=3A@9@\'8D.?GJ/
M.?E 5G/"C9KM%^H"G9=41E*T3YQWH%Y@ML66BM9DO4)KS-&C+ ']39>!UF)^
MG\E2_B#>OF#.,<VS&;L39^1>S#J59_&MJ-4+9FZO<&?<O:!2%7M[Q(;!W_Z&
M30;+$E#.T+HH0T.G>KTZHM]*X?<;06=XOIN:0!U\(?(R5C8,6@=(I? .4:<M
M$Y5*A'Y7LF\>!K\?$&)J2*[$Q]ZY5$WH!8R642L<E2H\0$QK'9!(*5+:[TM*
M1J*#)7N<Q"31D(@/.S;$?[Z^9]%&T2Q*-"K4WNV" \B4;'USG_<V!PR9+5U*
MD-0X;N S<>!8'OPRQ4N+?6._JR:VVBK;N+$SB$:V.3);N=(@*?+5S.])%O%D
M+6^Q=M6C(7/>Z!:3K;:O:<)"H&T,)J&F]=2Q?R3+),NYNN=>C3@=W1B@=]WU
M=]HVQP*K. AHAC@$1XMZ$*JB/'%T1ND&IQ_)FO$N?)HRU]383)JPU#5!,6(Q
M!J*AM4B+/1'QKPWF.>'I<R\4+:5K+@"K)AJ&+"@Z[-Y 0"JY7T9F'-,LD1U8
M+R1MJ?/+#<!LZ]+#T 7%"6 .OB2I]'Y)F=Z3-)6/:&#:WZ'8Q*YI@0V;O+25
M01$#V@.941&H" D'FXM'.3L7TZ2!E:WI?<+3LMW%3R4.%B'3X4"*5!B2<9Y(
MJCT:TL-02^F:'L"JR8TA"XH8NS>0%2U'2N\?D@L:#T*DTOD!Q+!IQZ,0!0A'
MTUD?&D+M$XS+)(MPJKU<BFWFSRL]6M> @'9-2%K"H$"!W(&PZ("2&17B%9C_
M$,R'X5)3^H&E9=6.2B4+$!336Q\F4N\%DO,-YPW7\(@#2UUATF>VY 32!0%*
MC[G6\TA:W@#%TPAT0?,D?Y9+'&XVEN>/[!)7;$#F2B;,_4&P )@R&= R)'5(
M"[VT?/DK <WEPA*P.J;,+0%VDTT*FIJ 2+ : VC8:=4Z'R]$G(N>B>/TBL9D
M^QMY!NO5TKEE K#9A,(0!42%W1F 12%&2HV$W L8=SQ98?X\3:*>H:(M=(L&
M9+3)AJD*" [ &D!'H4;3JW.?(\D,;Z]B 6JR2/0:O1Y*0+U;6'IL-YD!Q &A
MT^T0($@$H6:43Y"N:,3XFM4>=SAG&]$!/I^S&)ZA]$2YA6I0%9IH=88$!-@0
MGP!FC=!7^ID4Q.32:E4 DB5X(>XLCL6)RHI_KA-*CL#Z6[5NZ>JPVV3*(@R(
M)-@=P$^A?%5^0#(&W=)0H#G>HZK'_J$Y'@K-<=#0'+\$FMD3"P2:DSVJ>N(?
MFI.AT)P$#<W)BZ 1#>^UKSD7'V_YC#W9'LX&E5Z0:5NU K.3A8=+RUL?+#)
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M$&B;O+/?KK]Q/]Q?-[!'_@502P,$%     @ TD.)6O]C^AZM'   7L(  !@
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MUPN0\?"<,1B$L%'% ^'%/UXT=G9VZ/]QK7_!I(@+>__8>T5OH[#%QX(4@$-
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MLQ4]7+6K85=2$-;7Q U'#NNJ_7(G=_0:Y;QPR'#.[>HR+?V*9B[3H>HG.5J
MNWMTEUZ*\5P6=?,OC$=!S:KN;@S9:T4)UMT4Q(Y9+9*;BT.I;U@>8P(RB<GO
MQ:(<E6)E$ ]HGS["*@\>56J@J!1$WFI\UZ8=Q%&D)-?'^B9+(J24S6P6VE<V
MLS+D:I-$Z7$_-VG<,G]_C+>PF&$UKV8X9\.YTL;Z$X;PA,!SA?:U)H_ZII%W
MS&PZ+-54=B7Q0"FL54J?QF5]^)K2&R08[*UR"2278&^52["28W=?3&19K _<
M. .K"DM2]AJO7O_>V-MYO?UJ]WJA- '6G?M<@(-OS\C&JE@DY^O38*"_$I6X
M1:,C_Q)5#,['0->X+>4G>0X,%3Z?H_NL3GUI5U0^=;#I0CY!*>CEVZU3%ZL!
M_^+:LL'7*+X"=0[=@*AD5KZ9CE!SC6+4_E!O!': Y8NH@$94MLV%%(3<,/78
MT,(L(WP5FBJVAM7CJ+!<<C&TE+B1!HI5=DE@&%&AOU4='47!$5E@GB\5E8M,
M7,[;-CL!2X7A4E!X8]:;,6($<P_B1HGV YU.\DPYCS>8%+1GXY@+BL;SYKYH
MAA0:FFN%.ZHV?IY1LBEGZ$>!EG2H/ M-PFF@,E]CY7<87ZVNY=*NZ/3L"Y!?
M#R_GX5FG1=<3LT/@?L$4)GE(]7%$4'C=@BK\B4.X#;':4@WRE^^#&%MCL&^P
M*!!,+(W)2>J;J6YC" %Z(N7(K:]=@BY.3L_2DQIB= Z4GK"LP!0Y31Y82A)D
M)Y%.S65Q6 9:GZD4V:5O[_K@Z-]=F\)MSFIK17XW6='N=@EBJ=?JG'3GK._Q
MKO'A3> [6TISFQ=#5> =-="@RZ>FMEOP29PKG:(3!30W](J _!GF83B5#Y^&
M/'A"1_M1CO8+: HZ G7D"L:9>AM[.YM>X$]3]HXY3N;6<"@@.@=PZ :^9<,4
MG)#41W$ H@'DAC_!(NQ-%@>NYN:$"%B'F_A3QYG'>A$;C6D^9L.1(0NV=W;*
M1:F%B=#-QT5%:YLE4 #:48 IY 1\PRXYFUM>^BFF>0-9@_#R/9!P7U44K*]A
M1I.4'X[0F>-/"2]H9!_%L^]CY@0\B=2L/H\J #H,=-'/4]B?-,5-Y4P@JA!>
MW8<E6\I^]3Z,T!39>+%9.D'K#"_?AAFB#E0(GR5$V(?=MNL'>;7S>^/-SAN&
MUTJ]#2(J?E$*ZG19^P9A29\55=?#V6@7ELP"U:59//A*6%\>ZE3*^P=>FIU=
M ON@(2Q>RS[_HHN_*"I1!4_+*'XYF$/\)"I'^,>K-Z_F7L2\GPX23;%UN,?H
M92\>V?<Q$UFNQ(L=+TM\@N;"Z_!''.9CM?5%86D@YBN+ 7*>Z($R.^W.E"(E
ML]LO5>QBKO!^R4&06R'-0'U$4\B/,KT5Z#"GJ8)RFAD0+$PB#'T,4KQO?]#;
M"@/\VWP>\YZ[OM97)6"5 ,F4^,*0+$E82<J6++R^PK'I<+QT K8EAC'H%>7G
M ;N1\A%^$PZSKSD?81446+:E'%39!!A$&[M&9C+X@UQ^,E+ZL0ECE44.)<S/
M$E<A"(WY8Z'K+& >/A;,HC@AVJ(1%OC4^ I@5!D8T%\QAI@="R_0*;I)F"O-
MBRK"G4 H$@RL)<HX1":)^BL/\'[:")UQQF+T,$\>)F_[]1N,NSP-HK5KN4$H
MZ\4JE"6AK!>K4-:O<#E^ADMB;QNL6P/N?(^>B-6)7.MU:(-\-7Y#FVA1=2R2
M\[IL8);P7UW!RW )!$O* #-E<_4Z8Q6A7\G+*'32;7C-_?_]W.[A'Z<''GI2
M_VAUO(-V=_^HV?G4ZA:"_&[Q?1$#K3[ KP6>KH4%?1VD+T*@+<;T70 1/!?I
M]\>QH,EK<)=(O]_%@C:V#^7^B.XE*./!^IJXQPM$3/2EL+.C1 )D'S -</T%
M;C&%9QJ2]XQO8+$X:7V^!&80(#)!92VEH\?L0/B/"6O1>P/,XT+H[V\3J@YV
M#L<D)0YI#\(XI8]-OC4^S]X8(@>^:$!74AE?"I,QH9K[DG)$+?+I3ZE9;V!R
M9)'XC-HKVGM(E*;J"0X[BJ,M^SH!#5H-V<D/=(Z6]%>- 0/XGH_;A2FBBBKL
M@4A"_TK(!:N[,*R'@0 J2LLC^A/)":']X1U,[0:EO4$Q-TK00@J$#ZQKQH/K
M!Q;_A>PS;#HR'/@&,+W$WW+>%&+UP+[#TC5:!\4TKF#'&I7D.*1DK,!M8-;W
M%>;*$9&/P0XF(U6B<$(.])9)EYU'9#9V.),]@9XKO"FT/1.)6#*Z*_ O6Q,<
MKZ\1:B'C+Q>UP[QX#.SA_O.^XO.N_*E$/9&Q<DC0PAB^]3;\S=ETO7?>1K]X
MNU3' Q\--CEUMA*91*?BYCR#!#Y0DJ!N" [>&F[2S3+$)I1OUF6HWKI*RK5R
M<2)^._,.HHZ7DGN+G$1O?DKBNT7KFQ-T?3=_63+7\LK6US8N-FGGN9+:(ET8
MGPIZ9QJ5\S+</YSRR=E7<&GSD(X.>1%Q@T3W\TR*#1J5@];191Q>$F<EE-<!
M,*NAKT,D371WX.M8@NQPCW7JR@**'1MD#/K4>36DW\*5QA?4[\-PM7A 1T"9
MHN8B&1_+^IIL@HTN"/('AOI M,&%I+\B O=("7#1O8PE+'($,*=;$TYI.\EA
MPS;QO+*%10?,KNH?.&'..!]M>A8L7FBTC.Q($7>.V2,:>TBG;4$5J=+T-I3H
M3*EJ^%=9BJM2X25 6@L1$U@FB/XPF2%,3"1CWP^09."D+-0[7-/B:WD$GR:%
M=Y4($!0%+KY%#HM.!IX*TF#*>#"@-"D,$3/X2HZ^5WHN>0G7UU 6R!CD'#&3
MF/-L&I(A8,Q^:E".3 4:"C%\_R*.S3-(7..D ^6'1#I&H7&&A+G"I6':=.^,
M(I=ECHM F3KA&Y4(< P*+KJ+CO#%T>7!BW/_K3PX8;R%^\W]7UDPUP;7;FO!
M6-,A9A<<:C-]-?+#(>=-V%= (==:%HX)L;ZV6"5>8( X346,>3'2$U&+V9^(
M?#RGT(6Y"G*5T*%R$=O$?-*&B;T1=++5TMV)N^JPM7'2.;U#C.$RIYL. 34I
M1X%GY=TU2$KF#C NV!7-2G^HX1H&_GR+P#$6"EO+-98*N^([+5:(6:$66O0#
M6E\#>8LU0FPF57JCD!7FE0U08W\N,#\MO[^!^;D,1&(MPBA8$H(I6\4%E8",
M>3 R\1PJ 2'CD F3R$(3U4K_JOEP)R8J7*+;VZC>W9FH!7I;;1O5NYV)VIAG
MHX*!-]=(;5C[M&PGSEJK-[!-;V2G@8K*"FU52UAI!]=/^P:1EY>KR(M$7EZN
M(B^/G>3O*[M&$@G+S(@2"E'.H"^L#S(>/@XDF9^2" TL/'R06<!#FRM?^34A
M:TH'L;Z?:F.5 7_\*X_8P!7'&JD[<8H"6]@^,M"?XHG]KI0#M>+G>V)O(.70
M.UG'$\M>3H2P3RDK@1(?C'!:X(PROJH%/B>:A>-JI"^Z/B\;&RAYYHKPP*RX
MHP2A&;H+8JH@ 5V'>M XI2*D#:D(*&=@P@L+ZA^&9:?.2K ^;"CWQ?;ZVJ>S
M,["(FNW>$=E&^V=GYZU.L]<^._56B>;+N926/QC95C$FLD',C'*B!G$\P;(0
M\L@[#CER18^TDO(HL#6-59A.=**SV8@N)U[%>/71V,$DKHL4NY@E,1AI, (%
MB2*R@('_.9[/AM<'MH7\@ER?Y"PVYA[R*1(=\2 7UUWB9?Y7\SZH.F#=DG_/
M+Q(.?6JJ&7)U#<H'8BHY0NT 9TL8()C4PXK_T+&@%S,E=]5WSI7XW^V9/@8+
MR.7QE<7\3![UTN00-MM_M#KK:V>'7J?]Z:@WKPSF<5[G)\292B4PAC/!907=
M*PU1<:'<S&AJ75NL4^'EG-K@K@D4F] %< <.9]@8AHDJ&Q]!-90<"_BW\1$0
MF\JC-"?/F+(1HDH@JZKR?)>?.2O@FK](#=%YR,5VM"B.7F-7QP3#<M-YD>LB
M@L0,JN@W[.V^>KEG,T[UI0Z]_3BPV=X6];_ ;6//B'F>[)A'4-*4&1[Z5R0Z
MBJ#W7SGHGX$67;_H4,DXK+*6D=@(*7;:PP.!70#=6/BLL2 ( #,U7#7U=5!:
MB(&J @8?,,@JVRL_K_CPZ=SGW07"XTYO+VB#K5/0_HZ-W]P[.&MUO=.SGM?Z
MOUX+U,/>F;=_W&R?=+TO1^W](Z]WU/+V.ZV#=N^L4WSYWZ=G7SQXH_NY>][:
M[^&O6O_7[O:\]JEWU.[B1T>M#FB=?\!?S1X]I=<^:7G W%O_U]K_W&N??J*J
M6SL1&J[AM0_IX:?>QS_A22?F22>?X>%'S3]:WDFSU^JTF\?'?WK-PT,8O'7@
M#NG44GY!E1>'.&A]A-FOB@>6;"D?Y\F2.4@'CN3P@,,C+#7FZQLCWC@*ALKQ
M+U!^$KL8^#$^P4N1%Q_DE(@-8NJ.V!#0;+;AL1"ISB#SISE&Z>%=H%A,-#>V
M\ /63/UPP?/7U^8,4!(KV[#-V'9K! (-6\Z4[(3O8$4@IZ>V!Y&ZB#-=+6^G
M*B?TT./$29)PG1],4*/46!@WN_%>K=3O95*_7\DM/#U;7VL>G+2[7?0, )\^
M;C<_MH_;O3]7>OCR+>4T)EM=T$KF8,%<BP,#E]I!?1GZ><@WN83_@CR%PB^8
M=[,0=-2D^)3R*S$/PR882;)E3-EK6!G9E_)@FWVY74!>QP3_DG&F<T":**/@
M,!,'G;8$$#P<HD,@,,DDL\[TI\5K?@X!WV9)-X@(OEI%!"4B^.K7C BNQ/(/
M3/ZUB.7C]DF[1][Z+KG&V$MV;R)Y^;G7@XC?+^CG2@H_2Z2<U%F_<)/,\;B7
MH-H$+,-GQUEB8J[.LXK2!?-,SI?YZ3[MQTT./_-JOI&KN0]WLM?YO(^7<W4A
M']@OC4GWQ@(6\,Q+K:[$ML47I@J"/L7>?ZC%QI-)G&1YA#YF0M:\E%JETMVB
M>'DI#E?HHWDDK;+82^V/^_H"7=;K:Z6;CL&X9(*@X0%KVE8WEZJF(MK..C8&
M^1FN,<E#Q2JU/,(W>!V7FHH0AI0!4/K0J97B?9EZ5Z/8=%KUH]*T,9R&Z76L
M;1=%5D'B#[.4MM^Z14KA_06VAAZ2X]QL&,P*DV4#,%8R3H$-[ZF]X:.Y+#^3
M7?UFLN]/>ZU/G6:O=0"&_J=.BYVD*\;UL(RK!YP&SL/>*+I(.B-84[QK-L]+
M@FP.J*2-)3$T"AF^\V IP;S&1.9$DZU.H?%,C1&M+E(87W>RI,I5S)3EA;\P
MGD(*_* G59+OTQP3U<%.#\HL4BI A?6:]'3B'U%L,K>XT,P=S2@\F%*UOF;]
ME+)R9IRF)HG:^A4C)L;N%_ ]RSU1-9.Z:G$2C!O4R6%"02WM1B\I"!G,5J!L
MKZ^!(0=&7108"&8L58T#/=0#._-%;AAEP9GR"+VU BX*HV#Q+>=$!!ZFV?.R
M@CR<;CE]LBOI^]6\D#OGI(_FHOY,IOF[,,TBG/0.;FGGI+MUW#K]U#OR3EN?
MSGIM-LQ6/'19DA+*O-3>G+0,H>XZ-,D[R=%];6/<0<[=TGQ@L%NABBZR48D'
MEKF=P6H/*BP ZT 2Q;"?;LHNEBR6E%!L4#U0%ET!\=DLX)M.J-P-]VZB: ,%
MAE&P)QI%[&9NM =WA+.R@)6D<8@)5@S8K7D4X*]H:Y*.:$MN<4B3>-M ,$NM
MAB(+;'!)1 .HMW$D:5TET6'3.DBT$-O":F>R7B<Z0JY)3=1$RV4K5Z#)$RK1
MXC*>E:JX;#':84Z=!:^AND4Q1DN)Y<1%[HW$E=0@X!-,;X2O#$-VE J%<%$<
M"..9RZ<Q-9E01T&\PZ6X5.D<)6DF\9$,+4)#M*DOQM(I!D#!///CE*\F$#5<
ME"&A] ^>2(?N1RNR=W=L)+/7WI\'7;4ZD(<6U.BE 8E!< ,6\IXRU_)(5.E*
MTMY\G;JJ/)OW,<\B\C9*[Q6 Q,0KB"VACKV^QM]&D.Z8?[F)K 91)2QH)2%T
M4"X<!T75&'LZ;%"%Q0AQ3 ?Q9"J@*63DP -0M8@T]VK,$VU].8FZ -FN!&@%
MW2]@/Z!;!)_9P R+##42<I?H .M9LCR)+.8_-FM7\'M$@XFK<)B6'7).W]UF
MW)6(XJ43&GM8@=IK?CQN>?NMX^/SYL%!^_33OY[M/*/7W?/FOGE]RVLB8<#Y
M,<DK'60C?-K.?\$R>QTS"*;D !F'9BO@&0OV!J=_8'XFCYL3*J/<4PRW]@X^
M+/C!W2K2=H_+ _[D\VT/.19YT_\Y[;+>NC.&77W>Z^#?2!HK;?$[_'WWCL&
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M19!?S<%FTY%U:U Y8[&<VD3+M6_DX9/B1^*ZY/CR,>$QH7-/1U(OB-[LD*I
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M/ .83WV?%\JN@-3,E-SX-B6H,0<2N6&_:S#FC5^I(1Z7PC54]^J,QWDDJ9%
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M\"=>I^='O9/C#_\?4$L! A0#%     @ TD.)6M)(HC+. P  Z0X  !$
M         ( !     &%T;F8M,C R-3 T,#8N>'-D4$L! A0#%     @ TD.)
M6C*#!)0!"0  E&@  !4              ( !_0,  &%T;F8M,C R-3 T,#9?
M9&5F+GAM;%!+ 0(4 Q0    ( -)#B5K)_ <4\0L  !.0   5
M  "  3$-  !A=&YF+3(P,C4P-# V7VQA8BYX;6Q02P$"% ,4    " #20XE:
MIWM=44D(   N8P  %0              @ %5&0  871N9BTR,#(U,#0P-E]P
M<F4N>&UL4$L! A0#%     @ TD.)6O]C^AZM'   7L(  !@
M ( !T2$  &5A,#(S-S0Q-RTX:U\Q.#!L:69E+FAT;5!+ 0(4 Q0    ( -)#
MB5H9>*<8($4  (K5 0 =              "  ;0^  !E83 R,S<T,3<P,65X
F,3 M,5\Q.#!L:69E+FAT;5!+!08     !@ & )D!   /A      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>ea0237417-8k_180life_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ATNF="http://180lifesciences.com/20250406"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="atnf-20250406.xsd" xlink:type="simple"/>
    <context id="AsOf2025-04-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001690080</identifier>
        </entity>
        <period>
            <startDate>2025-04-06</startDate>
            <endDate>2025-04-06</endDate>
        </period>
    </context>
    <context id="From2025-04-062025-04-06_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001690080</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-06</startDate>
            <endDate>2025-04-06</endDate>
        </period>
    </context>
    <context id="From2025-04-062025-04-06_custom_WarrantsToPurchaseSharesOfCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001690080</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:WarrantsToPurchaseSharesOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-06</startDate>
            <endDate>2025-04-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-04-06" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-04-06" id="Fact000004">0001690080</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-04-06" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-04-06" id="Fact000010">2025-04-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-04-06" id="Fact000011">180 LIFE SCIENCES CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-04-06" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-04-06" id="Fact000013">001-38105</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-04-06" id="Fact000014">90-1890354</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-04-06" id="Fact000015">3000 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-04-06" id="Fact000016">Bldg. 4</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="AsOf2025-04-06" id="Fact000017">Suite 200</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-04-06" id="Fact000018">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-04-06" id="Fact000019">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-04-06" id="Fact000020">94306</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-04-06" id="Fact000021">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-04-06" id="Fact000022">507-0669</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-04-06" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-04-06" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-04-06" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-04-06" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-04-062025-04-06_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000027">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-04-062025-04-06_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000028">ATNF</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-04-062025-04-06_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-04-062025-04-06_custom_WarrantsToPurchaseSharesOfCommonStockMember"
      id="Fact000030">Warrants to purchase shares of Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-04-062025-04-06_custom_WarrantsToPurchaseSharesOfCommonStockMember"
      id="Fact000031">ATNFW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-04-062025-04-06_custom_WarrantsToPurchaseSharesOfCommonStockMember"
      id="Fact000032">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-04-06" id="Fact000033">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
